| Typicality: | 0.489 |
| Saliency: | 0.560 |
| further | 5 | manner |
| in this study | 5 | location |
| after brain injury | 3 | temporal |
| expression → be analyzed by → immunohistochemistry | 15 |
| expression → be detected by → immunohistochemistry | 12 |
| expression → be assessed by → immunohistochemistry | 12 |
| expression → be evaluated by → immunohistochemistry | 9 |
| expression → be determined by → immunohistochemistry | 7 |
| expression → be investigated by → immunohistochemistry | 7 |
| expression → be examined by → immunohistochemistry | 5 |
| expression → be studied by → immunohistochemistry | 3 |
| negative | neutral | positive |
| 0.095 | 0.859 | 0.046 |
| Raw frequency | 70 |
| Normalized frequency | 0.560 |
| Modifier score | 0.500 |
| Perplexity | 21.341 |